Circulating Levels of MicroRNA from Children with Newly Diagnosed Type 1 Diabetes and Healthy Controls: Evidence That miR-25 Associates to Residual Beta-Cell Function and Glycaemic Control during Disease Progression

<table> (a) A significant negative association between miR-25 one month after diagnosis and HbA1c (%) was shown at 3 months in the Danish Remission Phase Cohort (<i>P</i> = 0.003) while (b) stimulated C-peptide (pmol/L) was positively associated to miR-25 at the same time point (<i>P </i>= 0.0045).</table>

Journal of Diabetes Research

fig2

Figure 2

Figure 2: Circulating Levels of MicroRNA from Children with Newly Diagnosed Type 1 Diabetes and Healthy Controls: Evidence That miR-25 Associates to Residual Beta-Cell Function and Glycaemic Control during Disease Progression 

Figure 2 | Circulating Levels of MicroRNA from Children with Newly Diagnosed Type 1 Diabetes and Healthy Controls: Evidence That miR-25 Associates to Residual Beta-Cell Function and Glycaemic Control during Disease Progression 